Phathom Pharmaceuticals Inc (PHAT)
11.87
+0.17
(+1.45%)
USD |
NASDAQ |
Jun 18, 16:00
11.85
-0.02
(-0.17%)
After-Hours: 20:00
Phathom Pharmaceuticals Shareholders Equity (Quarterly): -148.50M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -148.50M |
| December 31, 2023 | -72.76M |
| September 30, 2023 | -17.77M |
| June 30, 2023 | 17.60M |
| March 31, 2023 | -90.20M |
| December 31, 2022 | -74.81M |
| September 30, 2022 | -26.42M |
| June 30, 2022 | -7.00M |
| March 31, 2022 | 38.04M |
| December 31, 2021 | 72.16M |
| September 30, 2021 | 103.48M |
| Date | Value |
|---|---|
| June 30, 2021 | 132.13M |
| March 31, 2021 | 164.34M |
| December 31, 2020 | 194.27M |
| September 30, 2020 | 156.39M |
| June 30, 2020 | 188.42M |
| March 31, 2020 | 208.70M |
| December 31, 2019 | 227.96M |
| September 30, 2019 | -152.46M |
| June 30, 2019 | -84.38M |
| December 31, 2018 | -1.286M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-152.46M
Minimum
Sep 2019
227.96M
Maximum
Dec 2019
41.46M
Average
27.82M
Median
Shareholders Equity (Quarterly) Benchmarks
| Regeneron Pharmaceuticals Inc | 26.99B |
| Rhythm Pharmaceuticals Inc | 61.58M |
| Xeris Biopharma Holdings Inc | -9.178M |
| Kodiak Sciences Inc | 241.19M |
| Biomea Fusion Inc | 135.31M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 356.50M |
| Total Liabilities (Quarterly) | 505.00M |
| Debt to Equity Ratio | -1.004 |
| Current Ratio | 7.831 |